The pharmaceutical company Eli Lilly has signed a series of contracts with four diabetes management companies to integrate them into the upcoming Tempo Pen...
Harith Rajagopalan, CEO of Fractyl Labs, envisions a scenario in which people with type 2 diabetes do not need insulin injections.
Insulin has long been...